Supernus Pharmaceuticals, Inc. Uncategorized Contracts & Agreements

20 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Exhibit 10.1+ Offer Letter to Timothy C. Dec
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2021
Offer Letter to James P. Kelly
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2020
Additional Convertible Bond Hedge Transaction, dated March 15, 2018, between JPMorgan Chase Bank, National Association, London Branch and Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Additional Convertible Bond Hedge Transaction, dated March 15, 2018, between Bank of America, N.A. and Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Additional Convertible Bond Hedge Transaction, dated March 15, 2018, between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Base Convertible Bond Hedge Transaction, dated March 14, 2018, between JPMorgan Chase Bank, National Association, London Branch and Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Base Convertible Bond Hedge Transaction, dated March 14, 2018, between Bank of America, N.A. and Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Base Convertible Bond Hedge Transaction, dated March 14, 2018, between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2017
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2017
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2017
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2016
Supernus to Receive $30 Million in Non-Dilutive Royalty Deal
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2014
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2014
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
PA
2013
COMPENSATORY ARRANGEMENTS WITH EXECUTIVE OFFICERS
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
COMPENSATORY ARRANGEMENTS WITH EXECUTIVE OFFICERS
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
OFFER LETTER TO EXECUTIVE OFFICER
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
Supernus Pharmaceuticals, Inc. 1550 East Gude Drive, Rockville, MD 20850 USA Phone: (301) 838-2500 Fax: (301) 838-2501 www.supernuspharma.com
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
Supernus Pharmaceuticals, Inc. 1550 East Gude Drive, Rockville, MD 20850 USA Phone: (301) 838-2500 Fax: (301) 838-2501 www.supernuspharma.com
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012